TQ Quiz | Herpes A to Z for the Eye Care Provider (Orlando 2023) by Events@optometricedu.com | Jun 15, 2023 | 2023 Orlando, TQ Courses | 0 comments "*" indicates required fields HiddenHerpes A to Z for the Eye Care ProviderHiddenDate (Hidden) MM slash DD slash YYYY HiddenEvent Date (Hidden) MM slash DD slash YYYY HiddenEvent 60 days past date (Hidden) MM slash DD slash YYYY HiddenEvent Date Difference (Hidden)1. How many herpes viruses cause eye disease?* A - One B - Three C - Five D - Eight 2. Herpes simplex virus keratitis is:* A - A leading cause of corneal blindness in the United States B - Primarily caused by HSV-2 C - Is never recurrent D - Can never lead to blindness 3. Taking into consideration herpes simplex viral infectious epithelial keratitis. Which is the most common?* A - Corneal vesicles B - Dendritic Ulcer C - Geographic Ulcer D - Marginal Ulcer 4. The herpes virus can lay dominant for years and reactivate to affect the eye. Which cranial nerve does it reside in to affect the cornea?* A - II B - III C - V D - VI 5. A 57-year-old patient presents to the office with a herpes zoster outbreak which is affecting the right side of his face and the right upper and lower eyelids. Which location of a herpes lesion would almost guarantee the globe is involved?* A - Right ear B - Upper lip C - Roof of the mouth D - Tip of the nose 6. Oral anti-viral medications such as Zovirax (acyclovir) and Valtrex (valacyclovir) are cleared and excreted from the body through the__________ so look and ask for________.* A - Heart, heart disease B - Kidney, renal impairment C - Lungs, asthma D - Large intestine, colon cancer 7. Which one is an anti-viral medication?* A - Zithromax (azithromycin) B - Keflex (cephalexin) C - Augmentin (amoxicillin and potassium clavulanate) D - Valtrex (valacyclovir) 8. A 37-year-old woman presents with a red and irritated right eye. This is the third time in the past year the patient has been diagnosed with herpetic keratitis. After discussing the risks and benefits, the patient is placed on oral __________ to decrease the risk of recurrence.* A - Vicodin HP (acetaminophen with hydrocodone) B - Vibramycin (doxycycline) C - Orasone (prednisone) D - Zovirax (acyclovir) 9. A study done by the National Eye Institute (NEI) found a maintenance dose of an oral anti-herpetic medication decreases recurrence by 41% within the 1st year. What study found this?* A - OHTS B - AREDS C - HEDS II D - AGIS 10. Which oral antiviral does not contain lactose?* A - Acyclovir 400 mg tablet B - Acyclovir 800 mg tablet C - Famciclovir 500 mg tablet D - Valacyclovir 1000 mg tablet 11. Which oral antiviral has the least amount of central nervous system side effects (hallucinations/confusion/agitation)?* A - Acyclovir 400 mg tablet B - Acyclovir 800 mg tablet C - Famciclovir 500 mg tablet D - Valacyclovir 1000 mg tablet 12. Which oral treatment for herpes is an essential amino acid?* A - L-Lysine B - Acyclovir C - Famciclovir D - Valacyclovir 13. Which vaccine has a 90% efficacy in herpetic disease?* A - Zostavax B - Shingrix C - Cervarix D - Prevnar 13 14. What type of pain is post herpetic neuralgia?* A - Nociceptive B - Inflammatory C - Alloplastic D - Neuropathic 15. Which medication would be best for post herpetic neuralgia?* A - Tylenol (acetaminophen) B - T3 (acetaminophen/codeine) C - Lortab (acetaminophen/hydrocodone) D - Gabapentin (Neurontin Alloplastic) 16. Which topical pharmaceutical was recently approved for treatment approved for neurotropic keratopathy?* A - Xelpros (latanoprost) B - Cequa (cyclosporine A) C - Oxervate (cenegermin) D - Inveltys (loteprednol etabonate) 17. Which herpetic keratitis is due to decreased ocular innervation and decreased tear production?* A - Epithelial keratitis B - Stromal keratitis C - Endotheliitis D - Neurotrophic keratopathy 18. Which rare retina condition is caused by the herpes virus?* A - Acute retinal necrosis B - Epiretinal membrane C - Macula hole D - Macula degeneration 19. The Herpetic Eye Disease Study found that after the first episode, the percent chance of getting another episode within a year is?* A - 25% B - 50% C - 75% D - 100% 20. The Herpetic Eye Disease Study found that after the second episode with a year, the percent chance of getting another episode within a year is?* A - 13% B - 43% C - 73% D - 93% Personal InformationName* First Last Email* Phone*OE Tracker # License # Address* Street Address Address Line 2 City State / Province / Region ZIP / Postal Code AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Country Payment InformationHiddenRetake Code Herpes A to Z for the Eye Care Provider | TQ Credit*After 8/16/2023, pricing will increase to $30. Price: (Past 60 Days) Herpes A to Z for the Eye Care Provider | TQ CreditThis course was presented over 60 days ago. Due to this late submission of TQ, your TQ credit price is $30. Price: Retake Discount Price: (Past 60 Days) Retake Discount Price: Paying Via Credit Card A Paypal account is not required to pay using the button below. To pay using a credit card, click the Paypal button below. A new window will appear and a button "Pay with Debit or Credit Card" is available at the bottom of that window for your convenience. Payment MethodPayPal CheckoutCredit Card American ExpressDiscoverMasterCardVisaSupported Credit Cards: American Express, Discover, MasterCard, Visa Card Number Card Number Expiration Date Expiration Date Security Code Security Code Cardholder Name HiddenCourse Information (HIDDEN)HiddenCourse Name (HIDDEN) HiddenRetake Code (HIDDEN) HiddenQuiz URL (HIDDEN)Do not include ending backslash (aka no .com/) HiddenCE Hours Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website
